Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-30

Clinical Trial Update: Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating guanfacine for reducing stress-induced cocaine and alcohol craving and relapse; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Yale University | Conditions: Cocaine Dependent, Alcohol Dependent | Phase 1 | Status: COMPLETED